Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy.
Saved in:
| Title: | Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy. |
|---|---|
| Authors: | Vetere G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Germani MM; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Antoniotti C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Salvatore L; Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy.; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Bensi M; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Ghelardi F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Calegari MA; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Intini R; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Minelli A; Clinical Oncology Unit, Hospital San Paolo, Civitavecchia, Rome, Italy., Sullo FG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Boccaccio C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Taravella A; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Puccini A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Lavacchi D; Clinical Oncology, University Hospital Careggi, Florence, Italy., Noto L; UOC Oncologia Medica, Policlinico 'G. Rodolico' - AOU Policlinico S. Marco, Catania, Italy., Salati M; Division of Medical Oncology, University Hospital of Modena, Modena, Italy., Scartozzi M; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, Pisa 56126, Italy.; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma, 67, Pisa 56126, Italy. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Jan 07; Vol. 17, pp. 17588359241299975. Date of Electronic Publication: 2025 Jan 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359241299975 |
